Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01650584 · ClinicalTrials.gov registry record · NA
Evaluation of Ocular Comfort With ISTA Tears vs Systane
A NA study of Dry Eye Disease, sponsored by Bausch & Lomb Incorporated.
- Completed
- Registry status
- NA
- Development phase
- 35
- Enrollment target
- 1
- Study location
NCT01650584: Completed NA study of Dry Eye Disease, sponsored by Bausch & Lomb Incorporated.
NCT01650584 is a NA study of Dry Eye Disease that has completed, run by Bausch & Lomb Incorporated. The registered enrollment target is 35 participants, below the 254-participant average among 33 other Dry Eye Disease trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01650584, a NA study of Dry Eye Disease, has completed, sponsored by Bausch & Lomb Incorporated.
- COMPLETED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
- 1
- Study location
Study Summary
To assess the comfort preference of ISTA Tears vs Systane in patients with dry eye disease (DED)
Primary Outcome
There were 35 participants who applied ISTA Tears to the right eye and Systane to the left eye (70 eyes total). Participants were asked to indicate which treatment they preferred, or if they preferred neither.
Conditions Studied
Interventions
- DRUG ISTA Tears
- DRUG Systane
Study Locations (1)
California
- ISTA Pharmaceuticals, Inc. - Irvine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2012-06 |
| Est. Completion | 2013-01 |
| Phase | NA |
What the finished NCT01650584 record still lists
NCT01650584 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 254-participant average among 33 other Dry Eye Disease trials with a reported enrollment target (86% lower).
The record links to 1 condition, with Dry Eye Disease appearing as the primary indexed condition, and to 2 interventions - of which ISTA Tears is the first listed.
NCT01650584 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01650584 about?
NCT01650584 is a clinical study titled "Evaluation of Ocular Comfort With ISTA Tears vs Systane". To assess the comfort preference of ISTA Tears vs Systane in patients with dry eye disease (DED)
What is the current status of trial NCT01650584?
This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2012-06. Estimated completion is 2013-01.
What conditions does trial NCT01650584 study?
This clinical trial studies the following conditions: Dry Eye Disease.
What interventions are being tested in trial NCT01650584?
The interventions under investigation include: ISTA Tears (DRUG), Systane (DRUG).
Who is sponsoring clinical trial NCT01650584?
This trial is sponsored by Bausch & Lomb Incorporated, which has 174 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01650584 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dry Eye Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01650584's enrollment target sits among peer trials
35 31st of 33 higher than 3 of 33 other Dry Eye Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Dry Eye Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Clinical Study Evaluating Nordlys™ SWT IPL for Dry Eye Disease (DED) Due to MGD
ACTIVE NOT RECRUITING · NA
-
The Visual Effect of an Investigational Artificial Tear in the Tear Layer.
COMPLETED · NA
-
In Vivo Confocal Microscopic Analysis of Corneal Nerve Changes After ProKera Slim® for Dry Eye
COMPLETED · NA
-
A Clinical Study to Evaluate the Effect and Side Effect of a New Artificial Tear Formulation (ABBV-444) Compared to Refresh Optive Unit Dose in Adult Participants With Dry Eye Disease
RECRUITING · Phase 3
-
A Study to Explore Signs, Symptoms, and Biomarkers in Dry Eye Disease Participants Following Anti-inflammatory Treatment
RECRUITING · Phase 4
-
Evaluating the Safety, Tolerability, and Efficacy of GRF312 5% in Participants With Dry Eye Disease (DED).
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia